5 news items
Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
STIM
7 May 24
information and indications for use, visit NeuroStar.com. "Safe harbor" statement under the Private Securities Litigation Reform Act
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
STIM
3 May 24
" statement under the Private Securities Litigation Reform Act of 1995:Statements in the press release regarding Neuronetics, Inc
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
STIM
27 Mar 24
" statement under the Private Securities Litigation Reform Act of 1995:Statements in the press release regarding Neuronetics, Inc
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
STIM
25 Mar 24
statement under the Private Securities Litigation Reform Act of 1995
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
STIM
5 Mar 24
NeuroStar.com. "Safe harbor" statement under the Private Securities Litigation Reform Act of 1995: Statements
- Prev
- 1
- Next